Royalty Pharma Raises Elan Corporation PLC (ELN) Bid to $12.50 a Share in Cash
5/21/2013 7:35:56 AM
More...
|
Royalty Pharma Seeks Lower Rate on $2.72 Billion of Loans
9/25/2012 7:56:43 AM
More...
|
Royalty Pharma AG Announces that James Reddoch, Ph.D., Joins Management Team
7/9/2008 11:36:21 AM
More...
|
Royalty Pharma AG Acquires Royalty Interest in RotaTeq(R) for $182 Million
4/25/2008 7:11:14 AM
More...
|
InNexus Biotechnology Inc. (IXS) To Host A Webcast Teleconference Detailing Recent News on Royalty Pharma AG Agreement & Preliminary Results of DXL625 Animal Study
2/8/2008 3:07:36 PM
More...
|
Royalty Pharma AG and InNexus Biotechnology Inc. (IXS) Announce Agreement Regarding the Purchase of a Second Royalty Right
2/8/2008 6:50:54 AM
More...
|
Royalty Pharma AG Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million
12/19/2007 7:24:06 AM
More...
|
Royalty Pharma AG and InNexus Biotechnology Inc. (IXS) Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
4/27/2007 12:17:33 PM
More...
|
Royalty Pharma AG and InNexus Biotechnology Inc. (IXS) Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
4/26/2007 12:27:51 PM
More...
|
Royalty Pharma AG Announces Agreement Regarding The Purchase Of The Rights To A Pre-Existing Royalty Interest In HUMIRA(R) From AstraZeneca PLC (AZN) And Cambridge Antibody Technology Group PLC (CATG)
10/26/2006 11:18:27 AM
More...
|
|